Request a Proof of Concept

Tag: artificial intelligence

Where are Pharma Companies in the Age of Artificial Intelligence?

They say good things come to those who wait; we say good things come to those who wait but only the things left by the visionaries before them.  The pharmaceutical industry has long been known to lag in the adoption of new technology due to strong regulations. Even though regulators have recently begun to open up to several new ‘big data’ or pharma 4.0 technologies - the question remains, if pharma companies are doing the same?  In 2016, the European Pharmacopoeia 9.0 in Chapter 5.21 announced that neural networks (NN) and support vector machines (SVM) are valid chemometric techniques for processing analytical data sets. 

Cultural Resistance… Who are the Real Enablers?

Advanced analytics technologies in the pharmaceutical industry are accessible now more than ever and regulators have slowly become more accepting of these kinds of advances.  The introduction of machine learning, artificial intelligence, and big data technologies are disrupting our industry, and it’s time we change our mindset.

Pharma 4.0 is here – we need to understand the compliance implications of big data and AI

With Pharma 4.0 comes a paradigm shift in many aspects. We in the pharma industry know all too well that every move we make needs to consider compliance with regulation - it's in everything that we do. Yet we can’t ignore the promise that these new technologies come with while at the same time speculating about the regulatory aspects. Although it may seem overwhelming right now, we must change the way we think.  New technologies such as big data, artificial intelligence, machine learning, and deep learning offer unprecedented analysis of real-time data and can even predict trends in processes, operations, and quality. You probably have heard this many times before, but it is truer this time than before.
Displaying page:
1
of 2